Expression of the aryl hydrocarbon receptor pathway and cyclooxygenase-2 in dog tumors

Research in Veterinary Science

Volumn 94, Issue 1, 2013, Pages 90-99

  Giantin, M ^a   Vascellari, M ^b   Lopparelli, R M ^a   Ariani, P ^b   Vercelli, A ^c   Morello, E M ^d   Cristofori, P ^e   Granato, A ^b   Buracco, P ^d   Mutinelli, F ^b   Dacasto, M ^a  

^a Dipartimento di Biomedicina comparata e Alimentazione   (Italy)

^b ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE   (Italy)

^c Ambulatorio Veterinario Associato   (Italy)

^d Dipartimento di Scienze veterinarie via Leonardo da Vinci 44   (Italy)

^e GSK   (Italy)

Author keywords

AhR gene battery; Dog cancer; Mammary tumor; Mast cell tumor; Osteosarcoma; Quantitative Real Time RT PCR

Indexed keywords

AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; CYCLOOXYGENASE 2; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; MASTOCYTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA ISOLATION; TUMOR BIOPSY; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CYCLOOXYGENASE 2; DOG DISEASES; DOGS; FEMALE; MALE; MAST-CELL SARCOMA; NEOPLASMS; OSTEOSARCOMA; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ARYL HYDROCARBON;

ANIMALIA; CANIS FAMILIARIS;

EID: 84871523030     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2012.07.035     Document Type: Article

References (57)

1. Androutsopoulos V.P., Tsatsakis A.M., Spandidos D.A. Cytochome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer 2009, 9:187.
2. Belguise K., Guo S., Yang S., Rogers A.E., Seldin D.C., Sherr D.H., Sonenshein G.E. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Research 2007, 67:11742-11750.
3. Buters J.T.M., Sakai S., Richter T., Pineau T., Alexander D.L., Savas U., Doehmer J., Ward J.M., Jefcoate C.R., Gonzalez F.J. Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proceedings of the National Academy of Sciences of the USA 1999, 96:1977-1982.
4. Carnevale V., Romagnoli E., Cipriani C., Del Fiacco R., Piemonte S., Pepe J., Scillitani A., Minisola S. Sex hormones and bone health in males. Archives of Biochemics and Biophysics 2010, 503:110-117.
5. Carver L.A., Hogenesch J.B., Bradfield C.A. Tissue specific expression of the rat Ah-receptor and ARNT mRNAs. Nucleic Acids Research 1994, 22:3038-3044.
6. Chang T.K.H., Chen J., Pillay V., Ho J.Y., Bandiera S.M. Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver. Toxicological Sciences 2003, 71:11-19.
7. Clarke B.L., Khosla S. Female reproductive system and bone. Archives of Biochemistry and Biophysics 2010, 503:118-128.
8. Currier N., Solomon S., Demicco E., Chang D., Farago M., Ying H., Dominguez I., Sonenshein G.E., Cardiff R.D., Xiao Z.X., Sherr D.H., Seldin D.C. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicologic Pathology 2005, 33:726-737.
9. Dolwick K.M., Schmidt J.V., Carver L.A., Swanson H.I., Bradfield C.A. Cloning and expression of a human Ah receptor cDNA. Molecular Pharmacology 1993, 44:911-917.
10. El-Rayes B.F., Ali S., Heilbrun L.K., Lababidi S., Bouwman D., Visscher D., Philip P.A. Cytochrome p450 and glutathione transferase expression in human breast cancer. Clinical Cancer Research 2003, 9:1705-1709.
11. Funatake C.J., Marshall N.B., Steppan L.B., Mourich D.V., Kerkvliet N.I. Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+ CD25+ cells with characteristics of regulatory T cells. Journal of Immunology 2005, 175:4184-4188.
12. Habano W., Gamo T., Sugai T., Otsuka K., Wakabayashi G., Ozawa S. CYP1B1, but not CYP1A1, is downregulated by promoter methylation in colorectal cancers. International Journal of Onoclogy 2009, 34:1085-1091.
13. Hahn M.E., Allan L.L., Sherr D.H. Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor. Biochemical Pharmacology 2009, 77:485-497.
14. Hawk E.T., Viner J.L., Dannenberg A., DuBois R.N. COX-2 in cancer - a player that's defining the rules. Journal of the National Cancer Institute 2002, 94:545-546.
15. Hayes H.M., Tarone R.E., Cantor K.P., Jessen C.R., McCuurnin D.M., Richardson R.C. Case-control study of canine malignant lymphoma: positive association with dog owner's use of 2,4-dichlorophenoxyacetic acid herbicides. Journal of the National Cancer Institute 1991, 83:1226-1231.
16. Gavazza A., Presciuttini S., Barale R., Lubas G., Gugliucci B. Association between canine malignant lymphoma, living in industrial areas, and use of chemicals by dog owners. Journal of Veterinary Internal Medicine 2001, 15:190-195.
17. Glickman L.T., Raghavan M., Knapp D.W., Bonney P.L., Dawson M.H. Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in scottish terriers. Journal of the American Veterinary Medical Association 2004, 224:1290-1297.
18. Gradin K., Toftgard R., Poellinger L., Berghard A. Repression of dioxin signal transduction in fibroblasts. Identification of a putative repressor associated with ARNT. Journal of Biological Chemistry 1999, 274:13511-13518.
19. Haarmann-Stemman T., Bothe H., Abel J. Growth factors, cytokines and their receptors as downstream targets of aryl hydrocarbon receptor (AhR) signaling pathways. Biochemical Pharmacology 2009, 77:508-520.
20. Khan Z., Khan N., Tiwari R.M., Sah N.K., Prasad G.B.K.S., Bisen P.S. Biology of Cox-2: an application in cancer therapeutics. Current Drug Targets 2011, 12:1082-1093.
21. Lee S., Jo M., Koh S.S., Kim S. Identification of novel universal housekeeping genes by statistical analysis of microarray data. Journal of Biochemistry and Molecular Biology 2007, 40:226-231.
22. Lin M.T., Lee R.C., Yang P.C., Ho F.M., Kuo M.L. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. Journal of Biological Chemistry 2001, 276:48997-49002.
23. Listgarten J., Damaraju S., Poulin B., Cook L., Dufour J., Driga A., Mackey J., Wishart D., Greiner R., Zanke B. Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. Clinical Cancer Research 2004, 10:2725-2737.
24. -ΔΔCt method. Methods 2001, 25:402-408.
25. Lucas J.N., Rudmann D.G., Credille K.M., Irizarry A.R., Peter A., Snyder P.W. The rat mammary gland: morphologic changes as an indicator of systemic hormonal perturbations induced by xenobiotics. Toxicologic Pathology 2007, 35:199-207.
26. Marshall N.B., Vorachek W.R., Steppan L.B., Mourich D.V., Kerkvliet N.I. Functional characterization and gene expression analysis of CD4+ CD25+ regulatory T cells generated in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Journal of Immunology 2008, 181:2382-2391.
27. Martinez V., Kennedy S., Doolan P., Gammell P., Joyce H., Kenny E., Mehta J.P., Ryan E., O'Connor R., Crown J., Clynes M., O'Driscoll L. Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue. Breast Cancer Research and Treatment 2008, 110:521-530.
28. Mimura J., Ema M., Sogawa K., Fujii-Kuriyama Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Development 1999, 13:20-25.
29. Misdorp W. Tumors of the mammary gland. Tumors in domestic animals 2002, 575-606. Iowa State press, Ames, IA. 4th edition. D.J. Meuten (Ed.).
30. Murray G.I., Taylor M.C., McFadyen M.C.E., McKay J.A., Greenlee W.F., Burke M.D., Melvin W.T. Tumor-specific expression expression of cytochrome P450 CYP1B1. Cancer Research 1997, 57:3026-3031.
31. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochemical Pharmacology 2000, 59:65-85.
32. Nishihashi H., Kanno Y., Tomuro K., Nakahama T., Inouye Y. Primary structure and organ-specific expression of the rat aryl hydrocarbon receptor repressor gene. Biological and Pharmaceutical Bulletin 2006, 29:640-647.
33. O'Brien D.J., Kaneene J.B., Poppenga R.H. The use of mammals as sentinels for human exposure to toxic contaminants in the environment. Environmental Health Perspectives 1993, 99:351-368.
34. Oyama T., Kagawa N., Kunugita N., Kitagawa K., Ogawa M., Yamaguchi T., Suzuki R., Kinaga T., Yashima Y., Ozaki S., Isse T., Kim Y.D., Kim H.K.T. Expression of cytochrome P450 in tumor tissues and its association with cancer development. Frontiers in Bioscience 2004, 9:1967-1976.
35. Patnaik A.K., Ehler W., MacEwen G. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Veterinary Pathology 1984, 21:469-474.
36. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., Caccamo M., Oukka M., Weiner H.L. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
37. Rasmussen R. Quantification on the light cycler. Rapid cycle real-time PCR: methods and applications 2001, 21-34. Springer, Heidelberg, Germany. S.C. Meuer, C. Wittwer, K. Nakagawara (Eds.).
38. Reif J.S., Dunn K., Ogilvie G.K., Harris C.K. Passive smoking and canine lung cancer risk. American Journal of Epidemiology 1992, 135:234-239.
39. Reif J.S., Lower K.S., Ogilvie G.K. Residential exposure to magnetic fields and risk of canine lymphoma. American Journal of Epidemiology 1995, 141:352-359.
40. Santin F., Stelletta C., Morgante M. Utilizzo degli animali domestici nella valutazione dei rischi di inquinamento ambientale: indagini epidemiologiche e studi sperimentali. Il Progresso veterinario 2005, 9:412-416.
41. Schilling R.J., Steele G.K., Harris A.E., Donahue J.F., Ing R.T. Canine serum levels of polychlorinated biphenyls (PCBs): a pilot study to evaluate the use of animal sentinels in environmental health. Archives of Environmental Health 1988, 43:218-221.
42. Schlezinger J.J., Liu D., Farago M., Seldin D.C., Belguise K., Sonenshein G.E., Sherr D.H. A role of aryl hydrocarbon receptor in mammary gland tumorigenesis. Biological Chemistry 2006, 387:1175-1187.
43. Shehin S.E., Stephenson R.O., Greenlee W.F. Transcriptional regulation of the human CYP1B1 gene: evidence for the involvement of an aryl hydrocarbon receptor response element in constitutive expression. Journal of Biological Chemistry 2000, 275:6770-6776.
44. Tanaka Y., Sasaki M., Kaneuchi M., Shiina H., Igawa M., Dahiya R. Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer. Biochemical Biophysical Research Communications 2002, 296:820-826.
45. Tang J., Le S., Sun L., Yan X., Zhang M., MacLeod J., LeRoy B., Northrup N., Ellis A., Yeatman T.J., Liang Y., Zwick M.E., Zhao S. Copy number abnormalities in sporadic canine colorectal cancers. Genome Research 2010, 20:341-350.
46. Trombino A.F., Near R.I., Matulka R.A., Yang S., Hafer L.J., Toselli P.A., Kim D.W., Rogers A.E., Sonenshein G.E., Sherr D.H. Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis. Breast Cancer Research and Treatment 2000, 63:117-131.
47. Tsuchiya Y., Nakajima M., Itoh S., Iwanari M., Tokoi T. Expression of aryl hydrocarbon receptor repressor in normal human tissues and inducibility by polycyclic aromatic hydrocarbons in human tumor-derived cell lines. Toxicological Sciences 2003, 72:253-259.
48. Uno S., Dalton T.P., Derkenne S., Curran C.P., Miller M.L., Shertzer H.G., Nebert D.W. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Molecular Pharmacology 2004, 65:1225-1237.
49. Uva P., Aurisicchio L., Watters J., Loboda A., Kulkarni A., Castle J., Palombo F., Viti V., Mesiti G., Zappulli V., Marconato L., Abramo F., Ciliberto G., Lahm A., La Monica N., de Rinaldis E. Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics 2009, 10:135.
50. Vail D.M., MacEwen E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Investigations 2000, 18:781-792.
51. Villano C.M., Murphy K.A., Akintobi A., White L.A. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. Toxicology and Applied Pharmacology 2006, 210:212-224.
52. Vogel C.F.A., Li W., Sciullo E., Newman J., Hammock B., Reader J.R., Tuscano J., Matsumura F. Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increase cycloossigenase-2 expression. American Journal of Pathology 2007, 171:1538-1548.
53. Wong P.S., Li W., Vogel C.F., Matsumura F. Characterization of MCF mammary epithelial cells overexpressing the aryl hydrocarbon receptor (Ahr). BMC Cancer 2009, 9:234.
54. Wulfing P., Diallo R., Muller C., Wulfing C., Poremba C., Heinecke A., Rody A., Greb R.R., Bocker W., Kiesel L. Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis. Journal of Cancer Research and Clinical Oncology 2003, 129:375-382.
55. Yamamoto J., Ihara K., Nakayama H., Hikino S., Satoh K., Kubo N., Iida T., Fujii Y., Hara T. Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: organ-specific distribution and variable induction patterns in mononuclear cells. Life Sciences 2004, 74:1039-1049.
56. Yang X., Solomon S., Fraser L.R., Trombino A.F., Liu D., Sonenshein G.E., Hestermann E.V., Sherr D.H. Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue. Journal of Cell Biochemistry 2008, 104:402-417.
57. Zudaire E., Cuesta N., Murty V., Woodson K., Adams L., Gonzalez N., Martinez A., Narayan G., Kirsch I., Franklin W., Hirsch F., Birrer M., Cuttitta F. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers. Journal of Clinical Investigations 2008, 118:640-650.